This following document details the Privacy Policy for the Whiteley Pty Ltd website, www.www.whiteley.com.au / www.whiteley.co.nz. Whiteley is committed to providing you with the best possible customer service experience. Whiteley is bound by the Privacy Act 1988, which sets out a number of principles concerning the privacy of individuals.
This privacy policy is published on Whiteley’s website – www.www.whiteley.com.au / www.whiteley.co.nz and may be updated from time to time at the discretion of Whiteley . By continuing to use the website, or otherwise continuing to deal with Whiteley Corporation, you accept this Privacy Policy as it applies from time to time.
Where you have subscribed to receive our newsletter(s), we are able to ensure you receive further relative and informative communications by following your interactions with that communication, such as whether you receive, open or click on a link within an email communication. We offer you an ability to unsubscribe in all our further communications.
There are many aspects of the site which can be viewed without providing personal information, however, for access to Whiteley Educational Material and Customer Support features you are required to submit personally identifiable information. This may include but not limited to a unique username and password, or submitting workplace facility details which are reviewed on a strictly confidential basis.
We may occasionally hire other companies to provide services on our behalf, including but not limited to handling customer support enquiries, processing transactions or customer freight shipping information. Those companies will be permitted to obtain only the personal information they need to deliver the service. Whiteley takes reasonable steps to ensure that these organisations are bound by confidentiality and privacy obligations in relation to the protection of your personal information.
For each visitor to reach the company’s website, we expressively collect the following non-personally identifiable information, including but not limited to browser type, version and language, operating system, pages viewed while browsing the website, page access times and referring website address. This collected information is used solely internally for the purpose of gauging visitor traffic, trends and delivering personalised content to you while you are at this website.
From time to time, we may use customer information for new, unanticipated uses not previously disclosed in our privacy notice. If our information practices change at some time in the future we will use for these new purposes only, data collected from the time of the policy change forward will adhere to our updated practices..
Whiteley may send marketing communications in line with an individual’s previously expressed marketing preferences or as otherwise permitted under the Privacy Act and other relevant laws such as the Spam Act 2003 (Cth). These marketing communications may be sent in various forms, including mail, SMS, fax and email, in accordance with applicable marketing laws. If you indicate a preference for a method of communication, we will endeavour to use that method whenever practical to do so. Individuals who do not wish to receive such communications can contact Whiteley Corporation at marketing@whiteley.com.au to modify their preferences, or follow the opt out instructions contained on each marketing communication.
Whiteley reserves the right to make amendments to this Privacy Policy at any time. If you have objections to the Privacy Policy, you should not access or use the website.
You have a right to access your personal information, subject to exceptions allowed by law. If you would like to do so, please contact marketing@whiteley.com.au. You may be required to put your request in writing for security reasons. Whiteley reserves the right to charge a fee for searching for and providing access to your information on a per request basis.
The security of Personal Information is important to Whiteley and takes reasonable steps to ensure that the Personal Information it holds is secure. Individuals should notify Whiteley immediately if they become aware of any breach of security.
Whiteley welcomes your comments regarding this Privacy Policy. If you have any questions about this Privacy Policy and would like further information, contact us.
Call: 1800 833 566 or +61 4961 9333
Post: Attn: Privacy Policy, Whiteley,
19-23 Laverick Ave Tomago NSW 2322
E-mail:Â marketing@whiteley.com.au
Whiteley offers advice, training and practical support for all of your infection prevention, medical device reprocessing, and professional cleaning needs.
You can view our product safety data sheets, technical bulletins and find out about the products from our range.
Speaker: Doctor Arthika Manoharan
Qualifications: Postdoctoral Research Fellow at University of Sydney
Speaker Profile:
Arthika is a Postdoctoral Research Fellow at The University of Sydney Infectious Diseases Institute, having recently completed her PhD in collaboration with Whiteley Corporation, under the supervision of Dr. Theerthankar Das and A/Prof Jim Manos. Her research aims to tackle biofilm formation in recurrent and catheter associated urinary tract infections, using antioxidants to circumvent antibiotic resistance and decipher how these antioxidants influence host-pathogen interactions in the bladder. A microbiologist with extensive immunology experience, Arthika has worked in various projects ranging from studying CAR T cells to antibiotic resistant biofilms. With 6 publications under her belt, Arthika is an enthusiastic early career researcher interested in multidisciplinary research that combines fundamental and translational sciences. She is also an avid advocate for EMCRs in the medical sciences, having served extensively on various EMCR committees university wide and in professional bodies, including ASM.
Topic: Rethinking biofilm treatments in catheter associated urinary tract infections
Presentation Outline: Catheter-associated urinary tract infections are a major issue in hospitals and age-care facilities. Biofilm formation in catheters can often result in encrustation and occlusion of the catheter, resulting in lack of urinary drainage and severe dissemination of infection. In my research, we investigated the novel effects of N-acetyl cysteine (NAC) on biofilm formation and matrix disruption using an in vitro glass bladder model. Furthermore, we also investigate the influence of NAC in host pathogen interactions, to elucidate how we can influence host cellular interactions to enhance biofilm removal.
Speaker: Professor Slade Jensen
Qualifications: B.Med.Sc. (USyd) PhD. (USyd). FASM
Speaker Profile:
Slade is a Professor of Microbiology and Infectious Diseases in the School of Medicine, Western Sydney University and Research Director of the Antibiotic Resistance and Mobile Elements Group, and the Limb Preservation and Wound Research Group, both of which are based at the Ingham Institute for Applied Medical Research. He obtained a Ph.D. from the University of Sydney focused on the role of horizontal gene transfer in bacterial evolution. His current research interests include the development of novel antimicrobials, the evolution of antibiotic resistance in hospital pathogens, such as ‘Golden Staph’, and the role of host-microbe interactions in disease progression, particularly in the context of diabetes-related foot ulcers.
Topic: Microbes, biofilms and diabetes-related foot ulcers
Presentation Outline: Slade will discuss how his team’s research has assisted in changing the understanding of the pathology of chronic ulceration in diabetic foot infections, from that of infection with planktonic bacteria to that of infection with biofilm. Due to the resistance of biofilms to antimicrobial penetration, increased emphasis is now given to removal of adequate volumes of tissue with debridement and the use of anti-biofilm compounds.
Speaker: Professor Kate Moore
Qualifications: MB BS Syd, MD Liv, FRCOG, FRANZCOG, CU
Speaker Profile:
Arthika is a Postdoctoral Research Fellow at the University of Sydney, having recently completed her PhD in collaboration with Whiteley Corporation, under the supervision of Dr. Theerthankar Das and A/Prof Jim Manos. Her research aims to tackle biofilm formation in recurrent and catheter associated urinary tract infections, using antioxidants to circumvent antibiotic resistance and decipher how these antioxidants influence host-pathogen interactions in the bladder. A microbiologist with extensive immunology experience, Arthika has worked in various projects ranging from studying CAR T cells to antibiotic resistant biofilms. With 6 publications under her belt, Arthika is an enthusiastic early career researcher interested in multidisciplinary research that combines fundamental and translational sciences. She is also an avid advocate for EMCRs in the medical sciences, having served extensively on various EMCR committees university wide and in professional bodies, including ASM.
Topic: Rethinking biofilm treatments in catheter associated urinary tract infections
Presentation Outline: Catheter-associated urinary tract infections are a major issue in hospitals and age-care facilities. Biofilm formation in catheters can often result in encrustation and occlusion of the catheter, resulting in lack of urinary drainage and severe dissemination of infection. In my research, we investigated the novel effects of N-acetyl cysteine (NAC) on biofilm formation and matrix disruption using an in vitro glass bladder model. Furthermore, we also investigate the influence of NAC in host pathogen interactions, to elucidate how we can influence host cellular interactions to enhance biofilm removal.
Speaker: Associate Professor Greg Whiteley
Qualifications: FEHA, MASM, MSHEA, PhD, M Safety Sc, B App, Dip AICD
Speaker Profile:
Dr Greg Whiteley is an Adjunct Associate Professor in the Faculty of Medicine and Health at the University of Sydney, a Fellow in the School of Medicine at Western Sydney University and is also the Executive Chairman of Whiteley Corporation. Assoc. Prof Whiteley’s qualifications include a Bachelor of Applied Science (Hawkesbury Agricultural College), a Master of Safety Science (University of New South Wales), a Diploma from the Australian Institute of Company Directors (University of New England) and a PhD (Western Sydney University).
Dr Whiteley is a Life Fellow of Environmental Health Australia, a Member of the Society of Healthcare Epidemiology of America and is a Member of the Australian Society of Microbiology. He currently serves as a director of the trade association known as ACCORD Australia, and also as an expert consultant to the Infection Control Committee for the Australian Dental Association. He has previously served on HE-023 with Standards Australia.
His on-going research interests focus on biofilms found within healthcare settings, healthcare hygiene and the cleanliness of medical devices. Findings from this research team include publications outlining the extent of biofilm problems within healthcare and other settings, monitoring solutions including ATP testing, and extensive findings on the cleaning and disinfecting implications from biofilms on healthcare surfaces and reusable medical devices.
Dr Whiteley has previously been an Industry Partner for an ARC Grant in conjunction with Macquarie University, a Collaboration Partner Study Director for an iMCRC Grant with the School of Medicine at Sydney University, the Study Director of a CRC-P Grant investigating novel diagnostic and treatment options for wound care co-jointly partnering with AMP Control and the University of Newcastle and Western Sydney University.
Dr Whiteley is currently the Executive Chairman of Whiteley Corporation. He bears ultimate responsibility under Commonwealth Legislation for the Therapeutic Goods registrations and the manufacturing license of the manufacturing location in Tomago. Dr Whiteley has additionally co-authored many patents and peer reviewed publications.
Topic: Advances in Biofilm TestingÂ
Presentation Outline: This topic will provide an overview into key lessons and research findings on dry surface and wet surface biofilms and their impact on critical healthcare departments. Published research on the presence of biofilms containing viable multi-resistant organisms and the critical role of rigorous cleaning processes to prevent hospital acquired infections (HAI’s). Understanding why cleaning protocols must adapt to account for our new logic of the role of biofilms in bacterial survival and transmission of infections.